These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 23368091)

  • 1. Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters.
    Ramboer E; Vanhaecke T; Rogiers V; Vinken M
    Drug Metab Rev; 2013 May; 45(2):196-217. PubMed ID: 23368091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of interspecies difference in hepatobiliary transporters to improve extrapolation of human biliary secretion.
    Lai Y
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1175-87. PubMed ID: 19611403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
    Feng B; Varma MV; Costales C; Zhang H; Tremaine L
    Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Sinusoidal Drug Uptake Transporter Activities in Primary Human Hepatocytes.
    Le Vée M; Jouan E; Denizot C; Parmentier Y; Fardel O
    Methods Mol Biol; 2015; 1250():287-302. PubMed ID: 26272151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting human hepatic clearance from in vitro drug metabolism and transport data: a scientific and pharmaceutical perspective for assessing drug-drug interactions.
    Camenisch G; Umehara K
    Biopharm Drug Dispos; 2012 May; 33(4):179-94. PubMed ID: 22407504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of hepatic transporter-mediated clinical drug-drug interactions: hepatocyte model optimization and retrospective investigation.
    Bi YA; Kimoto E; Sevidal S; Jones HM; Barton HA; Kempshall S; Whalen KM; Zhang H; Ji C; Fenner KS; El-Kattan AF; Lai Y
    Drug Metab Dispos; 2012 Jun; 40(6):1085-92. PubMed ID: 22381335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sandwich-Cultured Hepatocytes for Mechanistic Understanding of Hepatic Disposition of Parent Drugs and Metabolites by Transporter-Enzyme Interplay.
    Matsunaga N; Fukuchi Y; Imawaka H; Tamai I
    Drug Metab Dispos; 2018 May; 46(5):680-691. PubMed ID: 29352067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic drug transporters: the journey so far.
    Riley RJ; Foley SA; Barton P; Soars MG; Williamson B
    Expert Opin Drug Metab Toxicol; 2016; 12(2):201-16. PubMed ID: 26670591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic modeling of the hepatobiliary transport mediated by cooperation of uptake and efflux transporters.
    Kusuhara H; Sugiyama Y
    Drug Metab Rev; 2010 Aug; 42(3):539-50. PubMed ID: 20175646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry.
    Soars MG; Webborn PJ; Riley RJ
    Mol Pharm; 2009; 6(6):1662-77. PubMed ID: 19402709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional expression of sinusoidal drug transporters in primary human and rat hepatocytes.
    Jigorel E; Le Vee M; Boursier-Neyret C; Bertrand M; Fardel O
    Drug Metab Dispos; 2005 Oct; 33(10):1418-22. PubMed ID: 16014767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption.
    Harwood MD; Neuhoff S; Carlson GL; Warhurst G; Rostami-Hodjegan A
    Biopharm Drug Dispos; 2013 Jan; 34(1):2-28. PubMed ID: 22927116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transporters in hepatic drug disposition: an update.
    Li P; Wang GJ; Robertson TA; Roberts MS
    Curr Drug Metab; 2009 Jun; 10(5):482-98. PubMed ID: 19689245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane transporters in drug development.
    Keogh JP
    Adv Pharmacol; 2012; 63():1-42. PubMed ID: 22776638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional expression and regulation of drug transporters in monolayer- and sandwich-cultured mouse hepatocytes.
    Noel G; Le Vee M; Moreau A; Stieger B; Parmentier Y; Fardel O
    Eur J Pharm Sci; 2013 Apr; 49(1):39-50. PubMed ID: 23396053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated applications of sandwich-cultured hepatocytes in the evaluation of hepatic drug transport.
    Perry CH; Smith WR; St Claire RL; Brouwer KR
    J Biomol Screen; 2011 Apr; 16(4):427-35. PubMed ID: 21393626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocytes as a tool in drug metabolism, transport and safety evaluations in drug discovery.
    Sahi J; Grepper S; Smith C
    Curr Drug Discov Technol; 2010 Sep; 7(3):188-98. PubMed ID: 20843293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug trafficking: recent advances in therapeutics and disease.
    Sprowl JA; Sparreboom A
    Clin Pharmacol Ther; 2012 Nov; 92(5):531-4. PubMed ID: 23085872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6.
    Le Vee M; Lecureur V; Stieger B; Fardel O
    Drug Metab Dispos; 2009 Mar; 37(3):685-93. PubMed ID: 19074973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.